Newsroom
Company news
Business
Alvotech and Teva announce strategic partnership to collaborate in the U.S. biosimilar market
People
Tanya Zharov Joins Alvotech as Deputy CEO
Business
Alvotech announces positive top-line results for two comparative studies for AVT02, a proposed biosimilar to HUMIRA® (adalimumab)
Business
Alvotech and Alvogen launch new B2B business brand
Business
Delivering on our promise during the Coronavirus Pandemic
Business
Alvotech and DKSH partner to bring key biosimilar to Asia
Business
Alvotech and JAMP Pharma enter into an exclusive partnership for the commercialization of key biosimilars in Canada
Business
Alvotech at CPhI 2019
Business
Alvotech and Stada agree on strategic biosimilar partnership
Business